DelveInsight launched a new report on Adult T-Cell Leukemia-Lymphoma Epidemiology Forecast, 2030.
Adult T-cell leukemia/lymphoma is a rare and often aggressive (fast-growing) T-cell lymphoma that can be found in the blood (leukemia), lymph nodes (lymphoma), skin, or multiple areas of the body. Adult T-Cell Leukemia-Lymphoma has been linked to infection with the human T-cell lymphotropic virus type 1 (HTLV-1); however, less than five percent of individuals with HTLV-1 will develop Adult T-Cell Leukemia-Lymphoma. The HTLV-1 virus is most common in parts of Japan, the Caribbean, and some areas of South and Central America and Africa. Currently, physicians have no way of predicting which infected patients will develop Adult T-Cell Leukemia-Lymphoma.
DelveInsight’s ‘Adult T-Cell Leukemia-Lymphoma Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Adult T-Cell Leukemia-Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Adult T-Cell Leukemia-Lymphoma Epidemiology Report:
The age-standardized incidence of Adult T-Cell Leukemia-Lymphoma in non-endemic areas in Japan and in the US significantly increased during the period (1993 to 2006 for Japan) and (1993 to 2008) with an annual percent change of 95%.
The age-standardized incidence of Adult T-Cell Leukemia-Lymphoma in Japan-Honshu was +4.6% and in the United States was +6.2%.
Visit for more @ Adult T-Cell Leukemia-Lymphoma Epidemiology Insights
Scope of the Adult T-Cell Leukemia-Lymphoma Epidemiology report:
The Adult T-Cell Leukemia-Lymphoma report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Adult T-Cell Leukemia-Lymphoma Epidemiology Report and Model provide an overview of the risk factors and global trends of Adult T-Cell Leukemia-Lymphoma in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Adult T-Cell Leukemia-Lymphoma in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Adult T-Cell Leukemia-Lymphoma
The report provides the segmentation of the Adult T-Cell Leukemia-Lymphoma epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Adult T-Cell Leukemia-Lymphoma
3Adult T-Cell Leukemia-Lymphoma Epidemiology Overview at a Glance
4Adult T-Cell Leukemia-Lymphoma: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Adult T-Cell Leukemia-Lymphoma
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Adult T-Cell Leukemia-Lymphoma-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Adult T-Cell Leukemia-Lymphoma Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Adult T-Cell Le
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States